Respiratory Tract Diseases Clinical Trial
Official title:
Effect of a Medicated Topical Therapy, Petrolatum, and No Treatment on Nocturnal Cough and Congestion for Children With Upper Respiratory Infections
| Verified date | November 2017 |
| Source | Penn State University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.
| Status | Completed |
| Enrollment | 143 |
| Est. completion date | March 2010 |
| Est. primary completion date | March 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 2 Years to 11 Years |
| Eligibility |
Inclusion Criteria: - Cough and congestion attributed to upper respiratory tract infection Exclusion Criteria: - Children with signs or symptoms of more serious or treatable disease - Presence of itchy, watery eyes or frequent sneezing - Tachypnea (respiratory rate >95%ile) or labored breathing - Symptoms for 8 or more days - History of asthma in the past 2 years, chronic lung disease, or seizure disorder - History of an allergic reaction to camphor, menthol, eucalyptus, petrolatum, cedarleaf oil, nutmeg oil, thymol, turpentine oil, Over-the-counter medication containing VVR components |
| Country | Name | City | State |
|---|---|---|---|
| United States | Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| Penn State University | Procter and Gamble |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Subjective assessment of cough and congestion symptoms | 24 hours |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
| Withdrawn |
NCT04842331 -
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
|
Phase 2/Phase 3 | |
| Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
| Completed |
NCT01860898 -
A Phase I Study of iPS Cell Generation From Patients With COPD
|
N/A | |
| Completed |
NCT00984945 -
Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults
|
Phase 1 | |
| Completed |
NCT00382408 -
A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
|
Phase 3 | |
| Completed |
NCT01442779 -
Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis
|
Phase 2 | |
| Recruiting |
NCT05907564 -
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
|
N/A | |
| Not yet recruiting |
NCT05534685 -
Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia
|
N/A | |
| Completed |
NCT03739112 -
Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly
|
Phase 3 | |
| Active, not recruiting |
NCT04170348 -
Daily Vitamin D for Sickle-cell Respiratory Complications
|
Phase 2 | |
| Completed |
NCT05056766 -
How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
|
||
| Completed |
NCT01991587 -
Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05565872 -
Effects of Supervision During a Community-based Exercise Intervention (Urban Training) in Patients With COPD
|
N/A | |
| Not yet recruiting |
NCT05592431 -
Effect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in Neonates
|
N/A | |
| Completed |
NCT03401463 -
Assesment of the Endotracheal Tube Cuff Pressure Values in ICU Pateints Before and After Training Seminar
|
N/A | |
| Recruiting |
NCT02913365 -
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
|
N/A | |
| Active, not recruiting |
NCT01055990 -
Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
|
Phase 2 | |
| Completed |
NCT02198391 -
Study of Echinaforce Junior Tablets in Children With Acute Colds
|
||
| Terminated |
NCT04371978 -
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
|
Phase 3 |